Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters

Journal of Medicinal Food

Volumn 12, Issue 2, 2009, Pages 310-319

  Bhathena, Jasmine ^a   Martoni, Christopher ^a   Kulamarva, Arun ^a   Urbanska, Aleksandra M ^a   Malhotra, Meenakshi ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Atherosclerosis; Ferulic acid; Hypercholesterolemia; Microencapsulation; Probiotics; Triglycerides

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BACTERIAL CELL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; FEEDING; HAMSTER; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LACTOBACILLUS FERMENTUM; MALE; MICROCAPSULE; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL; CHOLESTEROL, LDL; CRICETINAE; DRUG COMPOUNDING; HYPERCHOLESTEROLEMIA; LACTOBACILLUS; LIPIDS; MALE; MESOCRICETUS; PROBIOTICS; TRIGLYCERIDES;

ANIMALIA; CRICETINAE; LACTOBACILLUS FERMENTUM;

EID: 67649514008     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0166     Document Type: Article

References (52)

1. Smith SC Jr, Jackson R, Pearson TA, et al.: Principles for national and regional guidelines on cardiovascular disease prevention - a scientific statement from the World Heart and Stroke Forum. Circulation 2004;109:3112-3121.
2. Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics - 2007 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:E69-E171.
3. Furberg CD, Pitt B: Withdrawal of cerivastatin from the world market. Curr Control Trials Cardiovasc Med 2001;2:205-207.
4. Packard CJ, Shepherd J: The hepatobiliary axis and lipoprotein metabolism - effects of bile-acid sequestrants and ileal bypass-surgery. J Lipid Res 1982;23:1081-1098.
5. Gill HS, Guarner F: Probiotics and human health: a clinical perspective. Postgrad Med J 2004;80:516-526.
6. Senok AC, Ismaeel AY, Botta GA: Probiotics: facts and myths. Clin Microbiol Infect 2005;11:958-966.
7. Mattila-Sandholm T, Myllarinen P, Crittenden R, et al.: Technological challenges for future probiotic foods. Int Dairy J 2002;12:173-182.
8. 2+-induced whey protein gel and effects on their viability in a dynamic gastro-intestinal model. J Microencapsul 2005;22: 603-619.
9. Champagne CP, Gardner NJ, Roy D: Challenges in the addition of probiotic cultures to foods. Crit Rev Food Sci Nutr 2005;45:61-84.
10. Balasubashini MS, Rukkumani R, Viswanathan P, Menon VP: Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother Res 2004;18:310-314.
11. Sri BM, Rukkumani R, Menon VP: Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol 2003;40: 118-122.
12. Ohnishi M, Matuo T, Tsuno T, et al.: Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice. Biofactors 2004;21:315-319.
13. Kamal-Eldin A, Frank J, Razdan A, et al.: Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000;35:427-435.
14. Ou S, Bao H, Lan Z: Advances on pharmacological study of ferulic acid and its derivatives. J Chin Med Mater 2001;24:220-221.
15. Kim HK, Jeong TS, Lee MK, Park YB, Choi MS: Lipid-lower-ing efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta 2003;327:129-137.
16. Adam A, Crespy V, Levrat-Verny MA, et al: The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats. J Nutr 2002;132:1962-1968.
17. Kern SM, Bennett RN, Mellon FA, Kroon PA, Garcia-Conesa MT: Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J Agric Food Chem 2003;51:6050-6055.
18. Bhathena J, Kulamarva A, Urbanska AM, Martoni C, Prakash S: Microencapsulated bacterial cells can be used to produce the enzyme feruloyl esterase: preparation and in-vitro analysis. Appl Microbiol Biotechnol 2007;75:1023-1029.
19. Prakash S, Jones ML: Artificial cell therapy: new strategies for the therapeutic delivery of live bacteria. J Biomed Biotechnol 2005;2005(1):44-56.
20. Bravo E, Cantafora A, Calcabrini A, Ortu G: Why prefer the golden Syrian hamster (Mesocricetus auratus) to the Wistar rat in experimental studies on plasma lipoprotein metabolism. Comp Biochem Physiol B Biochem Mol Biol 1994;107:347-355.
21. Friedewald W, Levy RI, Fredrickson DS: Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769.
23. Metchnikoff E: The Prolongation of Life. G.P. Putnam's Sons, New York, 1908.
24. Kiessling G, Schneider J, Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002;56:843-849.
25. Anderson JW, Gilliland SE: Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 1999;18:43-50.
26. Bukowska H, Pieczul-Mroz J, Jastrzebska M, Chelstowski K, Naruszewicz M: Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 1998;137:437-438.
27. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002;76:1249-1255.
28. Simons LA, Amansec SG, Conway P: Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis 2006;16:531-535.
29. Usman, Hosono A: Hypocholesterolemic effect of Lactobacillus gasseri SBT0270 in rats fed a cholesterol-enriched diet. J Dairy Res 2001;68:617-624.
30. duToit M, Franz CM, Dicks LM, et al.: Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int J Food Microbiol 1998;40:93-104.
31. DeSmet I, DeBoever P, Verstraete W: Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 1998;79:185-194.
32. Usman, Hosono A: Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci 2000;83:1705-1711.
33. Desmet I, Vanhoorde L, Desaeyer N, Vandewoestyne M, Verstraete W: In vitro study of bile salt hydrolase (BSH) activity of BSH isogenic Lactobacillus plantarum and 80 strains and estimation of cholesterol-lowering through enhanced BSH activity. Microb Ecol Health Dis 1994;7:315-329.
34. Wang XK, Geng X, Egashira Y, Sanada H: Purification and characterization of a feruloyl esterase from the intestinal bacterium Lactobacillus acidophilus. Appl Environ Microbiol 2004;50: 2367-2372.
35. Wende G, Buchanan CJ, Fry SC: Hydrolysis and fermentation by rat gut microorganisms of 2-O-beta-D-xylopyranosyl-(5-O-feruloyl)-L- arabinose derived from grass cell wall arabinoxylan. J Sci Food Agric 1997;73:296-300.
36. Andreasen MF, Kroon PA, Williamson G, Garcia-Conesa MT: Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals. J Agric Food Chem 2001;49:5679-5684.
37. Kroon PA, Faulds CB, Ryden P, Robertson JA, Williamson G: Release of covalently bound ferulic acid from fiber in the human colon. J Agric Food Chem 1997;45:661-667.
38. Bhathena J, Kulamarva A, Martoni C, Urbanska AM, Prakash S: Preparation and in vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tract. Biotechnol Appl Biochem 2008;50: 1-9.
39. Elkins CA, Mullis LB: Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid. Appl Environ Microbiol 2004;70:7200-7209.
40. Moser SA, Savage DC: Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli. Appl Environ Microbiol 2001;67:3476-3480.
41. Dorfman SE, Smith DE, Osgood DP, Lichtenstein AH: Study of diet-induced changes in lipoprotein metabolism in two strains of golden Syrian hamsters. J Nutr 2003;133:4183-4188.
42. Kahlon TS, Chow FI, Irving DW, Sayre RN: Cholesterol response and fatty streak formation in hamsters fed two levels of saturated fat and various levels of cholesterol. Nutr Res 1997;17:1693-1707.
43. Rukmini C, Raghuram TC: Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil - a review. J Am Coll Nutr 1991;10:593-601.
44. Fujiwara S, Noumi K, Sugimoto I, Awata N: Mass fragmentographic determination of ferulic acid in plasma after oral-administration of gamma-oryzanol. Chem Pharm Bull 1982;30:973-979.
45. Greany KA, Bonorden MJ, Hamilton-Reeves JM, et al.: Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2007;62:232-237.
46. Lovegrove J, Jackson K: Coronary heart disease. In: Functional Dairy Products (Mattila Sandholm T, Saarela M, eds.). Woodhill Publishing, Cambridge, UK, 2003, pp. 54-87.
47. Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D: Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 2007;18:105-112.
48. Jones ML, Chen HM, Wei OY, Metz T, Prakash S: Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol. J Biomed Biotechnol 2004;2004(1):61-69.
49. Dettmar PW, Strugala V, Tselepis C: The effect of alginates on deoxycholic-acid-induced changes in oesophageal mucosal biology at pH 4. J Biomater Sci Polym Ed 2007;18:317-333.
50. Neudorffer A, Bonnefont-Rousselot D, Legrand A, Fleury MB, Largeron M: 4-Hydroxycinnamic ethyl ester derivatives and related dehydrodimers: relationship between oxidation potential and protective effects against oxidation of low-density lipoproteins. J Agric Food Chem 2004;52:2084-2091.
51. Suzuki A, Yamamoto M, Jokura H, et al.: Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007;20:508-513.
52. Nguyen TDT, Kang JH, Lee MS: Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 2007;113: 358-361.